Detalhe da pesquisa
1.
Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study.
Cancers (Basel)
; 14(6)2022 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35326648